Bipolar Disorder

Patients can access bipolar drug Priadel for next five years

Bipolar disorder drug Priadel will be made available to patients at a reasonable price for the next five years.

Essential Pharma has agreed to continue supplying the drug to the NHS after the UK competition watchdog launched an investigation.

The head of the NHS in England has criticised Priadel manufacturer Essential Pharma for discontinuing the drug.

Health leaders have written to Matt Hancock urging him to ensure patients continue to have access to bipolar disorder drug Priadel.

The DHSC has told Pharmacy Network News it is disappointed at Essential Pharma’s decision to exit talks on Priadel 200mg and 400mg tablets.

Priadel 200mg and 400mg modified release tablets are to be discontinued, with all remaining supplies expected to run out by April of next year.